| |
| |
|
| Insider
Information: |
Singer Jack W |
| Relationship: |
EVP, Chief Scientific ... |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
994,057 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$9,035,978 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
994,057 |
|
|
| Total
Value |
$9,035,978 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cti Biopharma Corporation |
CTIC |
EVP, Chief Scientific ... |
2016-03-21 |
994,057 |
2003-12-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
73 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CTIC |
Cti Biopharma Corporation |
EVP, Research Program Chairman |
• • – |
2003-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
293,271 |
|
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Research Program Chairman |
• • – |
2004-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
333,476 |
|
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Medical Officer |
• • – |
2004-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
348,476 |
|
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Medical Officer |
• • – |
2005-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
444,178 |
|
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Medical Officer |
• • – |
2005-10-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,843 |
433,873 |
|
- |
|
| CTIC |
Cti Biopharma Corporation |
officerTitle |
• • – |
2005-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
456,290 |
|
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Medical Officer |
• • – |
2007-01-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(100,000) |
339,465 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Medical Officer |
• • – |
2007-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
84,675 |
168,841 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Medical Officer |
• • – |
2007-12-27 |
4 |
A |
$0.00 |
$0 |
D/D |
120,000 |
288,841 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Medical Officer |
• • – |
2008-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
103,884 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Medical Officer |
• • – |
2009-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
868,967 |
970,377 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Medical Officer |
• – – |
2009-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
875,981 |
1,846,358 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Medical Officer |
• • – |
2009-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,177,468 |
2,575,814 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Medical Officer |
• • – |
2009-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,048) |
2,140,579 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
Chief Medical Officer |
• • – |
2010-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
4,041,827 |
6,076,827 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Medical Officer |
• • – |
2010-12-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,000) |
6,068,827 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Medical Officer |
• • – |
2011-03-21 |
4/A |
A |
$0.00 |
$0 |
D/D |
250,000 |
6,318,827 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Medical Officer |
• • – |
2011-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
505,688 |
1,532,188 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Medical Officer |
• • – |
2011-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(673,636) |
858,552 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Medical Officer |
• • – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,639,414 |
2,497,966 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2012-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
37,161 |
2,527,534 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2013-03-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(68,174) |
414,330 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2013-03-21 |
4 |
A |
$0.00 |
$0 |
D/D |
296,705 |
711,035 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
See Remarks |
• • – |
2014-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
394,199 |
1,095,234 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2015-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
477,255 |
1,512,489 |
0 |
- |
|
73 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
